Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper.

Kaiser, Martin; Pratt, Guy; Bygrave, Ceri; Bowles, Kristian; Stern, Simon; Jenner, Matthew

Kaiser, Martin; Pratt, Guy; Bygrave, Ceri; Bowles, Kristian; Stern, Simon; Jenner, Matthew.

Afiliación

Kaiser M; Department of Haematology, The Royal Marsden Hospital, London, UK.
Pratt G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Bygrave C; Department of Haematology, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK.
Bowles K; Department of Haematology, University Hospital of Wales, Cardiff, UK.
Stern S; Department of Haematology, Norfolk and Norwich University Hospital, Norwich, UK.
Jenner M; Department of Haematology, Epsom and St Helier University Hospitals NHS Trust, Carshalton, UK.

Br J Haematol ; 205(3): 833-839, 2024 Sep.

Article en En | MEDLINE | ID: mdl-38952046

ABSTRACT

ABSTRACT

This Good Practice Paper provides recommendations for the diagnosis and initial management of transplant-eligible high-risk myeloma patients. It describes recent updates to the genetic diagnostics of high-risk myeloma and provides recommendations for treatment on the basis of recent prospective clinical trial evidence.

Asunto(s)

Mieloma Múltiple; Mieloma Múltiple/terapia; Mieloma Múltiple/diagnóstico; Humanos; Trasplante de Células Madre Hematopoyéticas; Reino Unido; Manejo de la Enfermedad

Palabras clave

highrisk multiple myeloma; stratified treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Haematol Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google